Capstone Investment Advisors
IOVA icon

Capstone Investment Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Capstone Investment Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,939
Closed -$136K – 2058
2024
Q2 		$136K Buy
+16,939
New +$182K ﹤0.01% 1846
2024
Q1 		– Sell
-20,785
Closed -$169K – 2428
2023
Q4 		$169K Sell
20,785
-7,722
-27% -$40.4K ﹤0.01% 1828
2023
Q3 		$130K Buy
28,507
+13,139
+85% +$85.8K ﹤0.01% 1910
2023
Q2 		$108K Buy
+15,368
New +$110K ﹤0.01% 1686

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return